Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.69 |
| ▸ | LMNA | P02545 | 4/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.61 |
| ▸ | SLC6A9 | P48067 | 4/20 | 0.60 |
| ▸ | SLC6A5 | Q9Y345 | 3/20 | 0.60 |
| ▸ | MAPT | P10636 | 5/20 | 0.60 |
| ▸ | THRB | P10828 | 1/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 2/20 | 0.55 |
| ▸ | IDE | P14735 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29723200 | 1.00 | ALDH1A1 (0.69) | ALDH1A1KMT2ALMNASMN1; SMN2SLC6A9 | |
| SCHEMBL5240348 | 0.96 | ALDH1A1 (0.64) | ALDH1A1KMT2ALMNASMN1; SMN2SLC6A9 | |
| SCHEMBL4379208 | 0.94 | ALDH1A1 (0.63) | ALDH1A1KMT2ALMNASMN1; SMN2SLC6A9 | |
| SCHEMBL5236073 | 0.92 | ALDH1A1 (0.60) | ALDH1A1KMT2ALMNASMN1; SMN2SLC6A9 | |
| SCHEMBL14464189 | 0.89 | ALDH1A1 (0.79) | ALDH1A1KMT2ALMNASMN1; SMN2SLC6A9 | |
| SCHEMBL30560071 | 0.88 | ALDH1A1 (0.62) | ALDH1A1KMT2ALMNASMN1; SMN2SLC6A9 | |
| SCHEMBL521191 | 0.88 | ALDH1A1 (0.62) | ALDH1A1KMT2ALMNASMN1; SMN2SLC6A9 | |
| SCHEMBL24267643 | 0.87 | ALDH1A1 (0.57) | ALDH1A1KMT2ALMNASMN1; SMN2SLC6A9 | |
| SCHEMBL4921368 | 0.86 | ALDH1A1 (0.75) | ALDH1A1KMT2ALMNASMN1; SMN2SLC6A9 | |
| SCHEMBL4163987 | 0.85 | ALDH1A1 (0.66) | ALDH1A1KMT2ALMNASMN1; SMN2SLC6A9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 241 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115389661-B | Method for detecting genotoxic impurities in linezolid glucose injection | 华润双鹤药业股份有限公司 | 2024-01-26 | — | — | CN | claimed |
| CN-115925647-A | Production method of linezolid | 湖北广济药业股份有限公司 | 2023-04-07 | — | — | CN | claimed |
| CN-115389661-A | Method for detecting genotoxic impurities in linezolid glucose injection | 华润双鹤药业股份有限公司 | 2022-11-25 | — | — | CN | claimed |
| CN-108339551-B | Preparation method of novel antibacterial drug linezolid intermediate | 扬州虹光生物科技有限公司 | 2021-05-28 | — | — | CN | claimed |
| EP-2563781-B1 | PROCESSES FOR PREPARING LINEZOLID | UNIV INDIANA RES & TECH CORP (US) | 2016-10-26 | — | — | EP | claimed |
| EP-2563781-A1 | PROCESSES FOR PREPARING LINEZOLID | Indiana University Research and Technology Corporation (US) | 2013-03-06 | — | — | EP | claimed |
| US-20130053557-A1 | PROCESSES FOR PREPARING LINEZOLID | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2013-02-28 | — | — | US | claimed |
| WO-2011137222-A1 | PROCESSES FOR PREPARING LINEZOLID | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2011-11-03 | — | — | WO | claimed |
| CN-1772750-A | Prepn process of (R)-N-(3-fluoro-4-morpholinyl phenyl)-oxazolone-5-methyl alcohol | UNIV ZHENGZHOU (CN) | 2006-05-17 | — | — | CN | claimed |
| WO-2025054339-A1 | TRIAZOLOPYRIDINE COMPOUNDS AS INHIBITORS OF KIT | ARCUS BIOSCIENCES, INC. (US) | 2025-03-13 | — | — | WO | disclosed |
| CN-118290358-A | Method for preparing linezolid key intermediate (S) -5- ((benzylamino) methyl) oxazolidine-2-one | 江苏医药职业学院 | 2024-07-05 | — | — | CN | disclosed |
| CN-117571871-A | Method for separating and detecting linezolid starting material M1 and related impurities thereof | 重庆华邦胜凯制药有限公司 | 2024-02-20 | — | — | CN | disclosed |
| CN-115389661-B | Method for detecting genotoxic impurities in linezolid glucose injection | 华润双鹤药业股份有限公司 | 2024-01-26 | — | — | CN | disclosed |
| CN-115389661-B | Method for detecting genotoxic impurities in linezolid glucose injection | 华润双鹤药业股份有限公司 | 2024-01-26 | — | — | CN | disclosed |
| WO-2002055013-A2 | THERAPEUTIC CHROMONE COMPOUNDS | ASTRAZENECA AB (SE) | 2002-07-18 | — | — | WO | disclosed |
| EP-0717738-B1 | SUBSTITUTED OXAZINE AND THIAZINE OXAZOLIDINONE ANTIMICROBIALS | UPJOHN CO (US) | 1999-10-20 | — | — | EP | disclosed |
| US-5880118-A | Substituted oxazine and thiazine oxazolidinone antimicrobials | PHARMACIA & UPJOHN COMPANY (US) | 1999-03-09 | — | — | US | disclosed |
| US-5688792-A | BACTERICIDES | PHARMACIA & UPJOHN COMPANY (US) | 1997-11-18 | — | — | US | disclosed |
| EP-0717738-A1 | SUBSTITUTED OXAZINE AND THIAZINE OXAZOLIDINONE ANTIMICROBIALS | PHARMACIA & UPJOHN COMPANY (US) | 1996-06-26 | — | — | EP | disclosed |
| WO-1995007271-A1 | SUBSTITUTED OXAZINE AND THIAZINE OXAZOLIDINONE ANTIMICROBIALS | THE UPJOHN COMPANY (US) | 1995-03-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130053557-A1 | PROCESSES FOR PREPARING LINEZOLID | CYP2C9, CYP2C19, CYP3A43 | ALDH1A1 703/4885KMT2A 958/4885LMNA 431/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.